Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | ||||||||||
| Cash from operating activities | 14.27%2.6M | -364.27%-14.37M | -140.73%-2.76M | 22.61M | 8.11M | -79.98%2.28M | 5.44M | 6.78M | 11.38M | 1,679.56%58.51M |
| Net profit before non-cash adjustment | -713.79%-12.15M | 138.41%1.36M | 1,697.68%4.66M | --2.1M | --3.39M | -30.99%1.98M | ---3.53M | --259K | --2.87M | -69.90%4.83M |
| Total adjustment of non-cash items | 2,388.27%14.44M | -50.74%1.62M | -680.84%-2.61M | ---185K | ---2.52M | -105.73%-631K | --3.3M | ---334K | --11.02M | 205.16%11.62M |
| -Depreciation and amortization | 200.71%1.7M | 778.76%1.7M | 730.05%1.69M | --2.66M | --1.7M | -93.97%565K | --193K | --203K | --9.37M | 1,040.47%11.55M |
| -Reversal of impairment losses recognized in profit and loss | 33.06%12.78M | --0 | -227.60%-4.25M | --9.66M | ---4.07M | --9.6M | --791K | --3.33M | ---- | ---- |
| -Disposal profit | --0 | --0 | --0 | ---11.95M | ---86K | ---10.69M | --2.52M | ---3.69M | --0 | ---- |
| -Net exchange gains and losses | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other non-cash items | 64.15%-38K | 65.22%-72K | 78.02%-40K | ---558K | ---63K | 80.04%-106K | ---207K | ---182K | ---531K | 97.87%-262K |
| Changes in working capital | -65.88%317K | -406.05%-17.35M | -170.14%-4.81M | --20.69M | --7.24M | 137.06%929K | --5.67M | --6.86M | ---2.51M | 2,574.29%42.06M |
| -Change in receivables | 100.17%326K | -631.80%-9.23M | -182.26%-12.94M | ---144.12M | --34.73M | -898.39%-196.32M | --1.74M | --15.74M | ---19.66M | 178.89%12.63M |
| -Change in payables | -100.00%-9K | -306.41%-8.12M | 191.63%8.13M | --164.81M | ---27.5M | 1,049.69%197.25M | --3.93M | ---8.88M | --17.16M | 108.97%29.43M |
| Dividends paid (cash flow from operating activities) | ||||||||||
| Dividends received (cash flow from operating activities) | ||||||||||
| Interest paid (cash flow from operating activities) | ||||||||||
| Interest received (cash flow from operating activities) | -61.68%41K | -65.58%74K | -78.13%42K | 576K | 62K | -43.39%107K | 215K | 192K | 189K | 546.34%265K |
| Tax refund paid | -43K | 0 | 0 | -45K | 0 | 0 | -6K | -39K | -117K | 80.00%-8K |
| Other operating cash inflow (outflow) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating cash flow | 9.06%2.6M | -353.18%-14.3M | -139.22%-2.72M | --23.14M | --8.17M | -79.17%2.39M | --5.65M | --6.94M | --11.45M | 1,683.58%58.77M |
| Investing cash flow | ||||||||||
| Net PPE purchase and sale | 100.22%43K | ---- | ---- | ---20M | --0 | -5.20%-20M | ---- | ---- | ---19.01M | -202,727.59%-58.82M |
| Net business purchase and sale | --0 | --0 | --0 | ---8.08M | ---7.28M | 294.29%476K | ---1.28M | ---3K | ---245K | ---- |
| Net investment product transactions | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Advance cash and loans provided to other parties | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Dividends received (cash flow from investment activities) | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Investing cash flow | 100.22%43K | 96.63%-43K | --0 | ---28.08M | ---7.28M | -1.39%-19.52M | ---1.28M | ---3K | ---19.26M | -223.60%-58.94M |
| Financing cash flow | ||||||||||
| Increase or decrease of lease financing | -581.82%-75K | 107.69%14K | 95.05%-9K | ---417K | ---42K | 94.88%-11K | ---182K | ---182K | ---215K | -252.46%-215K |
| Net other fund-raising expenses | ---- | ---- | ---- | --7.27M | --1K | 17,878.57%7.47M | --1K | ---202K | ---42K | 103.06%597K |
| Financing cash flow | -101.01%-75K | 107.73%14K | 97.66%-9K | --6.85M | ---41K | 3,001.17%7.46M | ---181K | ---384K | ---257K | -91.34%382K |
| Net cash flow | ||||||||||
| Beginning cash position | -85.21%4.68M | -30.90%19.01M | 31.77%21.74M | --16.5M | --21.41M | -43.70%31.66M | --27.51M | --16.5M | --56.24M | -0.71%56.43M |
| Current changes in cash | 126.53%2.57M | -441.91%-14.33M | -141.68%-2.73M | --1.9M | --846K | -20.11%-9.68M | --4.19M | --6.55M | ---8.06M | 101.98%208K |
| Effect of exchange rate changes | --0 | --0 | --0 | --3.34M | ---515K | -1,495.12%-572K | ---35K | --4.46M | --41K | -19,700.00%-396K |
| End cash Position | -66.12%7.25M | -85.21%4.68M | -30.90%19.01M | --21.74M | --21.74M | -55.60%21.41M | --31.66M | --27.51M | --48.22M | 21.41%56.24M |
| Free cash flow | 115.01%2.64M | -353.94%-14.34M | -139.22%-2.72M | --3.14M | --8.17M | -133.00%-17.62M | --5.65M | --6.94M | ---7.56M | -101.56%-51K |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.